2024-11-16  1:04:01 PM Chg. 0.000 Volume Bid1:04:01 PM Ask1:04:01 PM Market Capitalization Dividend Y. P/E Ratio
5.345EUR 0.00% -
Turnover: -
5.345Bid Size: - 5.465Ask Size: - 1.99 bill.EUR - -

Business description

Elekta is a human care company pioneering significant innovations and clinical solutions for treating cancer and brain disorders. The company develops sophisticated, state-of-the-art tools and treatment planning systems for radiation therapy, radiosurgery and brachytherapy, as well as workflow enhancing software systems across the spectrum of cancer care. Stretching the boundaries of science and technology, providing intelligent and resource-efficient solutions that offer confidence to both health care providers and patients, Elekta aims to improve, prolong and even save patient lives.
 

Management board & Supervisory board

CEO
Gustaf Salford
Management board
Tobias Hägglöv, Jonas Bolander, Anna Conneryd Lundgren, Habib Nehme, Maurits Wolleswinkel, John Lapré
Supervisory board
Laurent Leksell, Birgitta Stymne Göransson, Caroline Leksell Cooke, Cecilia Wikström, Jan Secher, Wolfgang Reim, Tomas Eliasson, Volker Wetekam
 

Company data

Name: Elekta AB
Address: Kungstensgatan 18,S-103 93 Stockholm
Phone: +46-8-587-254-00
Fax: +46-8-587-255-00
E-mail: info@elekta.com
Internet: www.elekta.com/
Industry: Healthcare
Sector: Medical Products
Sub sector: Advanced Medical Devices
End of financial year: 04-30
Free Float: -
IPO date: -

Investor relations

Name: Cecilia Ketels
IR phone: +46-707-6381-25
IR Fax: -
IR e-mail: cecilia.ketels@elekta.com

Company calendar

CW 48 | 2024-11-27 Interim Report 2nd Quarter/6 Months
CW 8 | 2025-02-21 Interim Report 3rd Quarter/9 Months
CW 22 | 2025-05-28 4th Quarter/Annual Report
 

Main Shareholders

Others
 
58.58%
Fourth Swedish National Pension Fund
 
9.06%
Laurent Leksell with company
 
5.72%
T. Rowe Price
 
4.55%
SEB Funds
 
3.75%
Nordea Funds
 
3.69%
Vanguard
 
3.37%
Swedbank Robur Funds
 
3.08%
Handelsbanken Funds
 
3.04%
Others
 
5.16%